𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The dynamic developmental localization of the full-length corticotropin-releasing factor receptor type 2 in rat cerebellum

✍ Scribed by Natalia V. Gounko; Dharamdajal Kalicharan; Vasily Rybakin; Albert Gramsbergen; Johannes J. L. Van Der Want


Book ID
109024497
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
593 KB
Volume
23
Category
Article
ISSN
0953-816X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cellular localization of the full-length
✍ Kyung-Hoon Lee; Georgia A. Bishop; Jin Bin Tian; Yoon-Jin Jang; Bao Chi Bui; Tru πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 660 KB

## Abstract Corticotropin releasing factor (CRF) and its cognate receptors, defined as Type 1 and Type 2 have been localized within the cerebellum. The Type 2 CRF receptor (CRF‐R2) is known to have both a full length (CRF‐R2Ξ±) and a truncated (CRF‐R2α‐tr) isoform. A recent study documented CRF‐R2Ξ±

Evidence for the presence of the type 2
✍ Georgia A. Bishop; Jin Bin Tian; Jennifer J. Stanke; Andy J. Fischer; James S. K πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 989 KB

## Abstract Corticotropin releasing factor (CRF), localized in afferent inputs to the cerebellum, binds to two receptors defined as the Type 1 (CRF‐R1) and the Type 2 (CRF‐R2Ξ±). CRF‐R1 has been localized to the cerebellum, as has a truncated isoform of CRF‐R2Ξ±. Evidence for the presence of the full

Characterization of native corticotropin
✍ Jelena Radulovic; Sabine Sydow; Joachim Spiess πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 476 KB

Corticotropin releasing factor (CRF), the most important regulator of various responses to stress, acts through CRF receptors (CRFR). For their characterization in brain tissue of Sprague-Dawley rats and C57BL/6J mice, a recently described polyclonal antibody directed against the N-terminus of rat C

Corticotropin-releasing factor (CRF) rec
✍ Ekaterini Chatzaki; Maria Lambropoulou; Theodoros C. Constantinidis; Nikolaos Pa πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 312 KB

## Abstract Corticotropin‐releasing factor agonists exert inhibitory effects in stomach functions possibly through peripheral routes. We have previously reported the expression of Urocortin (Ucn) I, an endogenous ligand of both CRF receptor types CRF~1~ and CRF~2~, in the human stomach. We examined